Acthar Gel for Active Systemic Lupus Erythematosus (SLE)
Public ClinicalTrials.gov record NCT02953821. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Efficacy and Safety of Acthar Gel in Subjects With Persistently Active Systemic Lupus Erythematosus Despite Moderate Dose Corticosteroids
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is to study Acthar Gel in participants with active systemic lupus erythematosus (SLE). The doctor will assign eligible patients to one of two groups (like flipping a coin). Participants will receive the treatment assigned to their group for 24 weeks: * Acthar Gel * Placebo Gel, which looks like Acthar Gel, but has no medicine in it. The doctor or his staff will take measurements and ask questions to: * see how well the gel is working * see how safe it is for patients with SLE
Study identification
- NCT ID
- NCT02953821
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 172 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 15, 2016
- Primary completion
- Jul 30, 2019
- Completion
- Oct 24, 2019
- Last update posted
- Aug 19, 2020
2016 – 2019
United States locations
- U.S. sites
- 16
- U.S. states
- 10
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| C.V. Mehta MD Medical Corporation | Hemet | California | 92543 | — |
| Inland Rheumatology Clinical Trials | Upland | California | 91786 | — |
| Center for Rheumatology Immunology and Arthritis | Fort Lauderdale | Florida | 33309 | — |
| San Marcus Research Clinic | Miami | Florida | 33015 | — |
| Advanced Pharma CR | Miami | Florida | 33147 | — |
| Millennium Research | Ormond Beach | Florida | 32174 | — |
| Office of George Timothy Kelly MD | Las Vegas | Nevada | 89128 | — |
| NewYork-Presbyterian Columbia University Medical Center | New York | New York | 10032 | — |
| DJL Clinical Research | Charlotte | North Carolina | 28210 | — |
| Paramount Medical Research & Consulting | Middleburg Heights | Ohio | 44130 | — |
| Arthritis & Rheumatology Center of Oklahoma | Oklahoma City | Oklahoma | 73103 | — |
| Altoona Center for Clinical Research | Duncansville | Pennsylvania | 16635 | — |
| West Tennessee Physicians' Alliance | Jackson | Tennessee | 38305 | — |
| Office of Ramesh C. Gupta, MD | Memphis | Tennessee | 38119 | — |
| Accurate Clinical Research | Houston | Texas | 77034 | — |
| Sun Research Institute | San Antonio | Texas | 78215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 23 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02953821, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 19, 2020 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02953821 live on ClinicalTrials.gov.